Immunopathogenesis of respiratory syncytial virus bronchiolitis.
about
Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection.Nitric oxide metabolites as biomarkers for influenza-like acute respiratory infections presenting to the emergency room.Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus.The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinationsPulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection.LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity.Lactate dehydrogenase and caspase activity in nasopharyngeal secretions are predictors of bronchiolitis severity.Respiratory syncytial virus and reactive airway diseaseMechanical ventilation drives inflammation in severe viral bronchiolitis.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsResveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.Role of hydrogen sulfide in paramyxovirus infections.Nasopharyngeal lactate dehydrogenase concentrations predict bronchiolitis severity in a prospective multicenter emergency department study.Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation.The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitisRespiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunitiesInnate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.Cellular and humoral immunity of virus-induced asthmaGene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis.Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6.Respiratory syncytial virus--a comprehensive review.Consolidation of molecular testing in clinical virology.The Human Immune Response to Respiratory Syncytial Virus Infection.Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice.Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.Systematic Analysis of Cell-Type Differences in the Epithelial Secretome Reveals Insights into the Pathogenesis of Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infections.Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection.Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis.Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium.Correlation between inflammatory mediators in the nasopharyngeal secretion and in the serum of children with lower respiratory tract infection caused by respiratory syncytial virus and disease severity.Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus.It is time for a comprehensive analytical approach in clinical studies. Virus-versus-host interaction and influenza disease severity.Immune monitoring of children with respiratory syncytial virus infection.Upregulation of interferon-induced genes in infants with virus-associated acute bronchiolitis.Suppression of interleukin-6 increases enterovirus A71 lethality in mice.Thiol-Activated Hydrogen Sulfide Donors Antiviral and Anti-Inflammatory Activity in Respiratory Syncytial Virus Infection.Protective Role of Nuclear Factor Erythroid 2-Related Factor 2 Against Respiratory Syncytial Virus and Human Metapneumovirus Infections.
P2860
Q30301182-212B2936-5C04-4851-9CDA-51E68F9DFADCQ30423817-5FEAA948-BCEF-42A4-B075-B9697775F063Q30431134-572888E5-D720-4398-A3D6-D156B4F40F82Q33586885-14F312D1-03A4-4751-8913-F623632658B3Q33905199-4450CE68-BCE2-40C8-9D3E-975CCC708C67Q34630095-51BFB6C8-B61C-4E19-BB68-B9E22182F670Q34671685-1EEFDB0D-CC5C-45E9-8BEC-386AC30CC108Q35065931-3958B79F-A060-45DB-86D7-63681ABF0794Q35070732-B913FFF7-41E4-499A-98CB-B3AD6F77541BQ35566601-F302C316-A420-44C8-8DE6-5B760DF471AAQ35599372-6D048782-D5B8-4BA5-83B1-7FE59D85411EQ35641468-BE0BB947-A66C-41D7-A544-6208CBBF5959Q36032678-885A9125-26C1-4128-849F-CE6901824E01Q36192895-016CFE34-85D9-4D0B-93F8-80318C91CE49Q36299483-17F62295-6736-491F-90A0-9C36941D8255Q36444085-E9969025-D652-42C1-8039-860AD9840159Q36727270-4114234C-A3BB-4004-8CD7-92882E16CF1BQ36946801-155E9279-FDD0-4DBB-B48E-10E45F7D1495Q36957257-23DC3ECC-EFF5-4FB4-B330-D48DA338EEBFQ37121841-C7C93D9A-DAF1-4A70-A322-8EDA271A813AQ37213863-5B5BBDC6-5169-4AF8-B230-38EC193D6DC4Q37372816-CEF59038-5226-4B00-892E-F151856D1F4EQ38098094-EC7FAC5C-6B74-40A9-B3D1-74B74005CFB8Q38779627-8DC3231D-74E0-4155-A41C-EE56D340C3F3Q39127064-FA23120E-5900-472B-9616-6C022FC06852Q39655682-67843D25-BA11-4C15-BC14-4FAB71227EE2Q39803969-F42E1835-8FA1-466A-A4F6-61F36471ABA9Q40309226-A2CE341F-5556-4029-B22D-DFFB4FAA5E95Q40476846-EA89A318-8918-4006-BE8F-521B4A54BE05Q40749296-8CC1BA3B-F1D9-4061-B27F-BDE8A9937F4EQ42276206-0151A75D-DECE-41D0-96C8-D32C0E7023A4Q44975553-651E0B73-4F4A-473D-B959-58E94BFB806CQ45264827-446F739C-5BE1-402F-9BC8-E6F16869532AQ45347845-EB8E5F18-AFD4-4A05-9B3E-0BF4FEA056C6Q45351448-B991D701-3C38-4B73-9DB9-5A9B477F94C0Q45399524-4C1016F0-A14B-4138-8F7B-0C63426B5EC0Q47103806-D82CD67F-ADFF-4D6B-B7EB-8D53F3C4B062Q54215265-5E9B21AE-C417-4E8F-BD15-D7402120751FQ54217591-7069D915-9EA8-4AF9-8261-3F3AA2B75B37
P2860
Immunopathogenesis of respiratory syncytial virus bronchiolitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Immunopathogenesis of respiratory syncytial virus bronchiolitis.
@en
Immunopathogenesis of respiratory syncytial virus bronchiolitis.
@nl
type
label
Immunopathogenesis of respiratory syncytial virus bronchiolitis.
@en
Immunopathogenesis of respiratory syncytial virus bronchiolitis.
@nl
prefLabel
Immunopathogenesis of respiratory syncytial virus bronchiolitis.
@en
Immunopathogenesis of respiratory syncytial virus bronchiolitis.
@nl
P2093
P356
P1476
Immunopathogenesis of respiratory syncytial virus bronchiolitis.
@en
P2093
Berkeley L Bennett
Charles G Macias
Pedro A Piedra
Roberto P Garofalo
Stanley G Cron
Yashoda M Hosakote
P304
P356
10.1086/515575
P407
P577
2007-04-12T00:00:00Z